Page last updated: 2024-11-07

dehydroalanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-ammonioprop-2-enoate : An amino acid zwitterion resulting from a transfer of a proton from the carboxy group to the amino group of 2-aminoacrylic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2-aminoacrylic acid : A 2,3-dehydroamino acid that is alanine which has been dehydrogenated to introduce a double bond between positions 2 and 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID123991
CHEBI ID17123
CHEBI ID76565
MeSH IDM0064133

Synonyms (33)

Synonym
CHEBI:17123
2-aminoacrylic acid
alpha,beta-dehydroalanine
2-aminoprop-2-enoic acid
C02218
2-aminoacrylate ,
1948-56-7
2-aminoprop-2-enoate
dehydroalanine
DB02688
2,3-didehydroalanine
2-amino-acrylic acid
anhydroserine 2-aminopropenoic acid
alpha-aminoacrylate
AKOS006342070
98ra387eky ,
2-propenoic acid, 2-amino-
unii-98ra387eky
2-propenoic acid,2-amino-
CHEBI:76565
2-ammonioprop-2-enoate
UQBOJOOOTLPNST-UHFFFAOYSA-N
.alpha.,.beta.-didehydroalanine
alanine, dehydro-
2-amino-2-propenoic acid
acrylic acid, 2-amino-
.alpha.-aminoacrylic acid
DTXSID90173131
(alpha)-(beta)-di-dehydroalanine
a-b-di-dehydroalanine
alpha-beta-di-dehydroalanine
Q1183089
PD007760

Research Excerpts

Overview

Dehydroalanine (Dha) is a nonproteinogenic electrophilic amino acid. It is a synthetic intermediate or product in the biosynthesis of several bioactive cyclic peptides such as lantibiotics and thiopeptides.

ExcerptReferenceRelevance
"Dehydroalanine (Dha) is a remarkably versatile non-canonical amino acid often found in antimicrobial peptides. "( Catalytic Modification of Dehydroalanine in Peptides and Proteins by Palladium-Mediated Cross-Coupling.
de Bruijn, AD; Roelfes, G, 2018
)
2.22
"Polydehydroalanine (PDha) is a polyampholyte featuring both a -NH"( Different Routes to Ampholytic Polydehydroalanine: Orthogonal versus Simultaneous Deprotection.
Biehl, P; Kruse, JH; Schacher, FH, 2019
)
1.35
"Dehydroalanine (Dha) is a nonproteinogenic electrophilic amino acid that is a synthetic intermediate or product in the biosynthesis of several bioactive cyclic peptides such as lantibiotics, thiopeptides, and microcystins. "( Phosphoserine Lyase Deoxyribozymes: DNA-Catalyzed Formation of Dehydroalanine Residues in Peptides.
Chandrasekar, J; Silverman, SK; Wylder, AC, 2015
)
2.1
"Dehydroalanine is a nonproteinogenic amino acid, but it is a component of a wide variety of natural products with therapeutic activities. "( Ribosomal synthesis of dehydroalanine-containing peptides.
Seebeck, FP; Szostak, JW, 2006
)
2.09

Effects

Dehydroalanine has emerged in recent years as a non-proteinogenic residue with strong chemical utility in proteins for the study of biology. The tag has since proven useful as a general precursor to many modifications after conjugate addition of various nucleophiles. phosphorylated, glycosylated, peptidylated and prenylated proteins are all accessible from dehydration.

ExcerptReferenceRelevance
"Dehydroalanine has emerged in recent years as a non-proteinogenic residue with strong chemical utility in proteins for the study of biology. "( Synthesis of modified proteins via functionalization of dehydroalanine.
Dadová, J; Davis, BG; Galan, SR, 2018
)
2.17
"The dehydroalanine tag has since proven useful as a general precursor to many modifications after conjugate addition of various nucleophiles; phosphorylated, glycosylated, peptidylated, prenylated, and even mimics of methylated and acetylated lysine-containing proteins are all accessible from dehydroalanine."( A "tag-and-modify" approach to site-selective protein modification.
Bernardes, GJ; Chalker, JM; Davis, BG, 2011
)
0.85
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
alkylating agentHighly reactive chemical that introduces alkyl radicals into biologically active molecules and thereby prevents their proper functioning. It could be used as an antineoplastic agent, but it might be very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. It could also be used as a component of poison gases.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
enamineAn amine RNR'R'' where R has a double bond adjacent to the amine nitrogen.
alpha,beta-unsaturated monocarboxylic acidA monocarboxylic acid in which the carbon of the carboxy group is directly attached to a C=C or C#C bond.
non-proteinogenic alpha-amino acidAny alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
2,3-dehydroamino acidA dehydroamino acid whose side-chain contains a double bond at the 2-3 position.
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (12)

PathwayProteinsCompounds
Serine Biosynthesis and Metabolism1020
Sulfur Metabolism2833
Sulfur Metabolism (Butanesulfonate)2834
Sulfur Metabolism (Propanesulfonate)2834
Sulfur Metabolism (Ethanesulfonate)2834
Sulfur Metabolism (Isethionate)2834
Sulfur Metabolism (Methanesulfonate)2834
Tryptophan Metabolism II623
Uracil Degradation III616
D-Serine Degradation27
Glycine and Serine metabolism ( Glycine and Serine metabolism )3649
ovothiol biosynthesis03

Research

Studies (184)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (5.98)18.7374
1990's34 (18.48)18.2507
2000's42 (22.83)29.6817
2010's71 (38.59)24.3611
2020's26 (14.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.43 (24.57)
Research Supply Index5.23 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index48.16 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (2.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other180 (97.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]